Raymond James Financial Inc Standard Biotools Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 3,881 shares of LAB stock, worth $5,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,881Holding current value
$5,122% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$100 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$77.4 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.4 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$13.3 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $104M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...